In a 24‑week pregnant patient with a 10‑day cough and a normal lung examination, should I prescribe azithromycin (Z‑Pack) and benzonatate?

Do Not Prescribe Azithromycin or Benzonatate for This Patient

In a 24-week pregnant patient with a 10-day cough and normal lung examination, antibiotics are not indicated, and benzonatate should be avoided due to lack of safety data in pregnancy. This is most likely a self-limited post-viral cough that does not require pharmacologic intervention.

Why Antibiotics Are Not Indicated

With a normal lung examination and 10-day duration, this presentation is consistent with post-infectious cough following an upper respiratory infection. There is no evidence of bacterial pneumonia (which would show abnormal lung sounds, fever, or systemic illness).

• Acute viral cough is almost invariably benign and prescribed treatment is generally unnecessary 1
• Antibiotics have no role in post-infectious cough when the cause is not bacterial 2
• The normal lung exam argues strongly against bacterial bronchitis or pneumonia that would warrant antibiotic therapy

Azithromycin in Pregnancy: Conflicting Evidence

While azithromycin is considered relatively safe in pregnancy for specific indications, the evidence is mixed:

Supporting safety:

• Classified as FDA Pregnancy Category B 3
• Recommended for pregnant patients with hidradenitis suppurativa 4
• Used successfully in documented bacterial infections during pregnancy 5

Concerning data:

• Recent animal studies show azithromycin can disturb fetal development with multi-organ toxicity, particularly affecting bone/cartilage, liver, and gonads 6
• Human studies report conflicting results regarding risks of spontaneous miscarriage, congenital malformations, preterm birth, and low birth weight 7
• Should only be used "when clinically indicated, if benefits outweigh potential risks" 7, 8

In this case, there is no documented bacterial infection to justify the risk.

Benzonatate: Avoid in Pregnancy

The FDA drug label for benzonatate is clear 9:

• Pregnancy Category C: "Animal reproduction studies have not been conducted with BENZONATATE. It is also not known whether BENZONATATE can cause fetal harm when administered to a pregnant woman"
• "Should be given to a pregnant woman only if clearly needed"
• No safety data exists for pregnancy

A symptomatic cough does not meet the threshold of "clearly needed" for a Pregnancy Category C medication with unknown fetal effects.

Recommended Management Approach

First-line: Supportive care and reassurance

• Simple "home remedies" such as honey and lemon are safe and may provide symptomatic relief 1
• Voluntary cough suppression techniques can reduce cough frequency 1
• Patient education that post-viral cough typically resolves within 3-8 weeks 2

If cough severely impacts quality of life:

• Consider inhaled ipratropium as it may attenuate post-infectious cough 2
• This has better evidence than systemic medications and avoids fetal exposure concerns

Red flags requiring further evaluation:

• Fever, purulent sputum, or worsening dyspnea (suggests bacterial superinfection)
• Hemoptysis
• Cough persisting beyond 8 weeks
• Development of abnormal lung sounds

Common Pitfalls to Avoid

1. Reflexive antibiotic prescribing for prolonged cough without evidence of bacterial infection
2. Underestimating the risks of medications in pregnancy, even those considered "probably safe"
3. Ignoring the efficacy of simple measures like honey-based remedies, which have patient-reported benefit
4. Failing to set expectations that post-viral cough can last 3-8 weeks normally

The safest approach for both mother and fetus is supportive care with close follow-up, reserving medications for documented bacterial infections or severe symptoms refractory to conservative management.